Domov › Rak trebušne slinavke › Texas › Dallas
Klinične študije za Rak trebušne slinavke v Dallas, TX
22 študij za Rak trebušne slinavke išče udeležence na lokacijah v Dallas in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
DESTINY-PANTUMOUR04
Vključevanje udeležencevOpazovalna študija
- Research Site, Dallas
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Vključevanje udeležencevFaza 2/3
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Medical Center-Zale Lipshy University Hospital, Dallas
- in še 1
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Vključevanje udeležencevFaza 3
- Texas Oncology - DFW, Dallas
- University of Texas, Southwestern Medical Center, Dallas
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Vključevanje udeležencevFaza 3
- Investigative Site US067, Dallas
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Vključevanje udeležencevFaza 3
- UT Southwestern Medical Center at Dallas, Dallas
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT - Dallas, Dallas
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
Vključevanje udeležencevOpazovalna študija
- University of Texas Southwestern/Children's Medical Center, Dallas
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Vključevanje udeležencevOpazovalna študija
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
Vključevanje udeležencevFaza 1
- University of Texas Southwestern Medical Center, Dallas
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Vključevanje udeležencevFaza 1
- Ut Southwestern, Dallas
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Vključevanje udeležencevFaza 3
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
Vključevanje udeležencevFaza 3
- University of Texas Southwestern Medical Center, Dallas
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Vključevanje udeležencevFaza 2
- Texas Oncology - DFW, Dallas
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Vključevanje udeležencevFaza 1
- Sarah Cannon Research Institute at Mary Crowley, Dallas
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Vključevanje udeležencevFaza 1/2
- Mary Crowley Cancer Research, Dallas
Evaluation of Resection Techniques for Pancreatic Tumors
Vključevanje udeležencevOpazovalna študija
- Methodist Dallas Medical Center, Dallas
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT Oncology - Dallas, Dallas
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Vključevanje udeležencevFaza 2
- Ohio State University-Telemedicine, Dallas
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
Vključevanje udeležencevFaza 1/2
- NEXT Oncology Dallas, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Dallas
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Mary Crowley Cancer Research, Dallas
- University of Texas Southwestern Medical Center, Dallas
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Vključevanje udeležencevOpazovalna študija
- Methodist Digestive Institute, Dallas
Študije za Rak trebušne slinavke v drugih mestih
- Houston, TX61 študij
- New York City, NY60 študij
- Boston, MA43 študij
- Nashville, TN39 študij
- Los Angeles, CA35 študij
- St. Louis, MO33 študij
- Arlington, VA33 študij
- Baltimore, MD31 študij
- San Antonio, TX31 študij
- Philadelphia, PA26 študij
- Tampa, FL26 študij
- Durham, NC24 študij
Druge študije v Dallas
- Rak dojke55 študij
- Nemalicelični pljučni rak52 študij
- Metastatski rak42 študij
- Srčno popuščanje42 študij
- Rak (vse vrste)37 študij
- Rak prostate36 študij
- Kolorektalni rak33 študij
- Debelost30 študij
- Rak jajčnikov28 študij
- Rak pljuč27 študij
- Rak mehurja27 študij
- Rak endometrija24 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.